These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28162890)

  • 1. BioBank Japan project: Epidemiological study.
    Kubo M;
    J Epidemiol; 2017 Mar; 27(3S):S1. PubMed ID: 28162890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japan launches controversial Biobank project.
    Triendl R
    Nat Med; 2003 Aug; 9(8):982. PubMed ID: 12894146
    [No Abstract]   [Full Text] [Related]  

  • 3. [BioBank Japan project].
    Ohnishi Y; Nakamura Y
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():35-41. PubMed ID: 16416768
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of the BioBank Japan Project: Study design and profile.
    Nagai A; Hirata M; Kamatani Y; Muto K; Matsuda K; Kiyohara Y; Ninomiya T; Tamakoshi A; Yamagata Z; Mushiroda T; Murakami Y; Yuji K; Furukawa Y; Zembutsu H; Tanaka T; Ohnishi Y; Nakamura Y; ; Kubo M
    J Epidemiol; 2017 Mar; 27(3S):S2-S8. PubMed ID: 28189464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BioBank Japan Project.
    Nakamura Y
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):696-7. PubMed ID: 17982410
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological Studies.
    Saklatvala JR; Hanscombe KB; Mahil SK; Tsoi LC; Elder JT; Barker JN; Simpson MA; Smith CH; Dand N
    J Invest Dermatol; 2023 Aug; 143(8):1598-1601.e10. PubMed ID: 36870556
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases.
    Hirata M; Kamatani Y; Nagai A; Kiyohara Y; Ninomiya T; Tamakoshi A; Yamagata Z; Kubo M; Muto K; Mushiroda T; Murakami Y; Yuji K; Furukawa Y; Zembutsu H; Tanaka T; Ohnishi Y; Nakamura Y; ; Matsuda K
    J Epidemiol; 2017 Mar; 27(3S):S9-S21. PubMed ID: 28190657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study designs for biobank-based epidemiologic research on chronic diseases.
    Läärä E
    Methods Mol Biol; 2011; 675():165-78. PubMed ID: 20949387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.
    Ukawa S; Nakamura K; Okada E; Hirata M; Nagai A; Yamagata Z; Muto K; Matsuda K; Ninomiya T; Kiyohara Y; Kamatani Y; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S65-S70. PubMed ID: 28215481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of BioBank Japan follow-up data in 32 diseases.
    Hirata M; Nagai A; Kamatani Y; Ninomiya T; Tamakoshi A; Yamagata Z; Kubo M; Muto K; Kiyohara Y; Mushiroda T; Murakami Y; Yuji K; Furukawa Y; Zembutsu H; Tanaka T; Ohnishi Y; Nakamura Y; ; Matsuda K
    J Epidemiol; 2017 Mar; 27(3S):S22-S28. PubMed ID: 28190660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobanks and registers in epidemiologic research on cancer.
    Pukkala E
    Methods Mol Biol; 2011; 675():127-64. PubMed ID: 20949386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beset by practical hurdles, UK Biobank moves at sluggish pace.
    Watson J; Cyranoski D
    Nat Med; 2005 Jul; 11(7):696. PubMed ID: 16015344
    [No Abstract]   [Full Text] [Related]  

  • 13. Governing UK Biobank: the importance of ensuring public trust.
    Tutton R; Kaye J; Hoeyer K
    Trends Biotechnol; 2004 Jun; 22(6):284-5. PubMed ID: 15158057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with liver cancer in the BioBank Japan project.
    Ukawa S; Okada E; Nakamura K; Hirata M; Nagai A; Matsuda K; Yamagata Z; Kamatani Y; Ninomiya T; Kiyohara Y; Muto K; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S43-S48. PubMed ID: 28214185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active recruitment and limited participant-load related to high participation in large population-based biobank studies.
    van Zon SK; Scholtens S; Reijneveld SA; Smidt N; Bültmann U
    J Clin Epidemiol; 2016 Oct; 78():52-62. PubMed ID: 27032874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. For what am I participating? The need for communication after receiving consent from biobanking project participants: experience in Japan.
    Watanabe M; Inoue Y; Chang C; Hong H; Kobayashi I; Suzuki S; Muto K
    J Hum Genet; 2011 May; 56(5):358-63. PubMed ID: 21390038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological specimen banks: epidemiological tools and scientific enterprises].
    Muti P
    Epidemiol Prev; 2003; 27(2):121-5. PubMed ID: 12848025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biobanks must be used rationally. Stop quarreling about the ownership!].
    Dahlquist G
    Lakartidningen; 2002 Sep; 99(36):3484-5. PubMed ID: 12362746
    [No Abstract]   [Full Text] [Related]  

  • 19. The Norwegian Multiple Sclerosis Registry and Biobank.
    Myhr KM; Grytten N; Aarseth JH
    Acta Neurol Scand Suppl; 2012; (195):20-3. PubMed ID: 23278652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project.
    Tamakoshi A; Nakamura K; Ukawa S; Okada E; Hirata M; Nagai A; Matsuda K; Kamatani Y; Muto K; Kiyohara Y; Yamagata Z; Ninomiya T; Kubo M; Nakamura Y;
    J Epidemiol; 2017 Mar; 27(3S):S36-S42. PubMed ID: 28214186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.